enGene Therapeutics Inc. Shares Outstanding (Cover Page)
enGene Therapeutics Inc. (ENGN) had Shares Outstanding (Cover Page) of 67.02 million shares as of 2026-09-02, per its 10-Q filed 2026-09-08.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-09-08
- 2026-09-02: Entity Common Stock, Shares Outstanding 67.02M shares.
- 2026-06-09: Entity Common Stock, Shares Outstanding 66.99M shares.
- 2026-03-03: Entity Common Stock, Shares Outstanding 66.99M shares.
- 2026-02-17: Entity Common Stock, Shares Outstanding 66.99M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-09-02 | 67.02M shares 10-Q · filed 2026-09-08 |
| 2026-06-09 | 66.99M shares 10-Q · filed 2026-06-15 |
| 2026-03-03 | 66.99M shares 10-Q · filed 2026-03-09 |
| 2026-02-17 | 66.99M shares 10-K/A · filed 2026-02-19 |
| 2025-12-18 | 66.98M shares 10-K · filed 2025-12-22 |
| 2025-09-10 | 51.19M shares 10-Q · filed 2025-09-11 |
| 2025-06-09 | 51.11M shares 10-Q · filed 2025-06-12 |
| 2025-03-05 | 50.98M shares 10-Q · filed 2025-03-10 |
| 2025-02-14 | 50.98M shares 10-K/A · filed 2025-02-20 |
| 2024-12-16 | 50.98M shares 10-K · filed 2024-12-19 |
| 2024-09-06 | 44.22M shares 10-Q · filed 2024-09-10 |
| 2024-06-11 | 44.17M shares 10-Q · filed 2024-06-14 |
| 2024-03-07 | 43.58M shares 10-Q · filed 2024-03-11 |
| 2024-01-25 | 23.20M shares 10-K · filed 2024-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |